文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Kala-azar--progress against a neglected disease.

作者信息

Murray Henry W

出版信息

N Engl J Med. 2002 Nov 28;347(22):1793-4. doi: 10.1056/NEJMe020133.

DOI:10.1056/NEJMe020133
PMID:12456856
Abstract
摘要

相似文献

[1]
Kala-azar--progress against a neglected disease.

N Engl J Med. 2002-11-28

[2]
Oral miltefosine in the treatment of kala-azar.

Natl Med J India. 2000

[3]
Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.

Int J Dermatol. 2010-5

[4]
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.

J Assoc Physicians India. 2003-7

[5]
Availability of miltefosine for the treatment of kala-azar in India.

Bull World Health Organ. 2005-5

[6]
Treatment of leishmaniasis with miltefosine: 2008 status.

Expert Opin Drug Metab Toxicol. 2008-9

[7]
An oral drug for leishmaniasis.

N Engl J Med. 2002-11-28

[8]
Oral miltefosine in the treatment of post-kala-azar dermal leishmaniasis.

Clin Exp Dermatol. 2008-1

[9]
Miltefosine--the long-awaited therapy for visceral leishmaniasis?

N Engl J Med. 1999-12-9

[10]
Miltefosine for visceral leishmaniasis.

N Engl J Med. 2000-3-23

引用本文的文献

[1]
Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis.

Trop Med Infect Dis. 2024-9-19

[2]
Multitarget Compounds for Neglected Diseases: A Review.

Curr Drug Targets. 2024

[3]
A Case Series of Hemophagocytic Lymphohistiocytosis: An Atypical Presentation of Visceral Leishmaniasis.

Cureus. 2024-4-14

[4]
Autochthonous and Imported Visceral Leishmaniasis in Bulgaria-Clinical Experience and Treatment of Patients.

Pathogens. 2024-2-26

[5]
Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects.

Pathogens. 2022-12-26

[6]
Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics.

Microorganisms. 2022-9-21

[7]
In vitro effect of artemether-loaded nanostructured lipid carrier (NLC) on .

J Parasit Dis. 2021-12

[8]
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.

Molecules. 2021-7-30

[9]
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 174: A 25-year-old pregnant woman from Afghanistan with headache and a blast flag in the automated differential blood count.

Wien Klin Wochenschr. 2020-7

[10]
Susceptibility to leishmaniasis is affected by host SLC11A1 gene polymorphisms: a systematic review and meta-analysis.

Parasitol Res. 2019-6-23

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索